These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22558876)

  • 1. [Therapy and prophylaxis of migraine].
    Diener HC; Rabe K
    MMW Fortschr Med; 2012 Apr; 154(7):52-5. PubMed ID: 22558876
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecule of the month. Telcagepant.
    Drug News Perspect; 2009 Mar; 22(2):115. PubMed ID: 19330169
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term tolerability of telcagepant for acute treatment of migraine in a randomized trial.
    Connor KM; Aurora SK; Loeys T; Ashina M; Jones C; Giezek H; Massaad R; Williams-Diaz A; Lines C; Ho TW
    Headache; 2011 Jan; 51(1):73-84. PubMed ID: 21070230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimigraine efficacy of telcagepant based on patient's historical triptan response.
    Ho TW; Olesen J; Dodick DW; Kost J; Lines C; Ferrari MD
    Headache; 2011 Jan; 51(1):64-72. PubMed ID: 21054362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CGRP-receptor antagonism in migraine treatment.
    Edvinsson L
    Lancet; 2008 Dec; 372(9656):2089-90. PubMed ID: 19036426
    [No Abstract]   [Full Text] [Related]  

  • 6. Telcagepant, a calcitonin gene-related peptide antagonist for the treatment of migraine.
    Tepper SJ; Cleves C
    Curr Opin Investig Drugs; 2009 Jul; 10(7):711-20. PubMed ID: 19579177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent tolerability but relatively low initial clinical efficacy of telcagepant in migraine.
    Tfelt-Hansen P
    Headache; 2011 Jan; 51(1):118-23. PubMed ID: 21070229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sustained pain freedom and no adverse events a clinically relevant endpoint in acute migraine treatment?
    Tfelt-Hansen P
    Cephalalgia; 2011 Aug; 31(11):1240. PubMed ID: 21335365
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained pain freedom and no adverse events as an endpoint in clinical trials of acute migraine treatments: application to patient-level data from a trial of the CGRP receptor antagonist, telcagepant, and zolmitriptan.
    Dodick DW; Kost J; Assaid C; Lines C; Ho TW
    Cephalalgia; 2011 Feb; 31(3):296-300. PubMed ID: 20937606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of migraine: present and future].
    Massiou H
    Rev Med Interne; 2010 Jun; 31(6):399-402. PubMed ID: 20416986
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy and prophylaxis of migraine].
    Hoffmann J; Reuter U
    MMW Fortschr Med; 2009 Apr; 151(14):114-7; quiz 118. PubMed ID: 19504851
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the vasoconstrictor effects of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) and zolmitriptan in human isolated coronary arteries.
    Lynch JJ; Regan CP; Edvinsson L; Hargreaves RJ; Kane SA
    J Cardiovasc Pharmacol; 2010 May; 55(5):518-21. PubMed ID: 20164785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Migraine can signal a risk for heart and brain].
    Vetter C
    MMW Fortschr Med; 2009 Sep; 151(37):17. PubMed ID: 19827419
    [No Abstract]   [Full Text] [Related]  

  • 14. New drugs in migraine treatment and prophylaxis: telcagepant and topiramate.
    Edvinsson L; Linde M
    Lancet; 2010 Aug; 376(9741):645-55. PubMed ID: 20416945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for migraine.
    Treat Guidel Med Lett; 2011 Feb; 9(102):7-12; quiz 14. PubMed ID: 21304447
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute migraine medications and evolution from episodic to chronic migraine].
    Haag G
    MMW Fortschr Med; 2009 Feb; 151(6):41, 43. PubMed ID: 19432251
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of acute and chronic migraine.
    Coppola G; Schoenen J
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):177-82. PubMed ID: 22406987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of combination therapy in migraine: a review of the clinical evidence.
    Taylor F; Smith T
    Postgrad Med; 2006 Apr; Spec No():27-31. PubMed ID: 17960688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current understanding and treatment of headache disorders: five new things.
    Marmura MJ; Silberstein SD
    Neurology; 2011 Feb; 76(7 Suppl 2):S31-6. PubMed ID: 21321349
    [No Abstract]   [Full Text] [Related]  

  • 20. Answers to frequently asked questions about migraine.
    Garza I; Swanson JW
    Mayo Clin Proc; 2006 Oct; 81(10):1387-91; quiz 1392. PubMed ID: 17036564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.